Hepatic Veno-Occlusive Disease clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 1 month to 99 years
To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obstruction syndrome (SOS), mild to moderate SOS, and severe to very severe SOS. Secondarily, the investigators would also like to quantify the temporal relationship between US SWE changes and SOS diagnosis according to various clinical criteria (Modified Seattle, Baltimore, EBMT consortium).
Our lead scientists for Hepatic Veno-Occlusive Disease research studies include Christine Higham, MD.